-
181
Primary Gliosarcoma of the Cerebellum in a Young Pregnant Woman: Management Challenges and Immunohistochemical Features
Published 2019-01-01“…GS should be considered in the differential diagnosis of posterior cranial fossa tumors with radiological features of meningioma or glioblastoma, even in young patients. To this regard, sarcomas, solitary fibrous tumors, and even metastases should be considered, especially in light of the tendency of GS to give rise to extracranial localizations. …”
Get full text
Article -
182
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real‐World Study
Published 2025-01-01“…Moreover, TERTp mutation tended to co‐occur with EGFR, KRAS, and MET in glioblastoma. In the IDH‐mutant subgroup, it tended to co‐occur with CIC and FUBP1 alterations, while being mutually exclusive with ATRX and TP53 alterations. …”
Get full text
Article -
183
Update on the Progress of Musashi-2 in Malignant Tumors
Published 2025-01-01“…As a significant member of the MSI family, MSI2 is closely associated with multiple malignant tumors, including hematological disorders, common abdominal tumors, and other tumor types (e.g., glioblastoma, breast cancer). MSI2 is highly expressed in the majority of tumors and is related to a poor disease prognosis. …”
Get full text
Article -
184
Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells
Published 2025-01-01“…Gliomas comprise high-grade gliomas like glioblastoma multiforme (GBMs), many of which have mutation in the tumor suppressor p53 gene and low-grade gliomas (LGGs). …”
Get full text
Article -
185
Predicting survival in malignant glioma using artificial intelligence
Published 2025-01-01“…Abstract Malignant gliomas, including glioblastoma, are amongst the most aggressive primary brain tumours, characterised by rapid progression and a poor prognosis. …”
Get full text
Article -
186
Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1
Published 2025-02-01“…In this study, we show that this protein also upregulates the immune checkpoint molecule PD‐L1 under conditions of stress in breast and glioblastoma cancer cells, revealing a previously unknown connection between stemness programs, stress responses, and immune checkpoint control. …”
Get full text
Article -
187
Aqp 9 and Brain Tumour Stem Cells
Published 2012-01-01“…We, therefore, propose that aquaporin 9 may have a central role in the tumorigenesis of glioblastoma.…”
Get full text
Article -
188
Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
Published 2012-01-01“…Immunotherapy is making inroads towards effectively treating other fatal cancers, such as melanoma, glioblastoma multiforme, and castrate-resistant prostate cancers. …”
Get full text
Article -
189
Gliosarcoma with Primary Skull Base Invasion
Published 2016-01-01“…Gliosarcoma is an uncommon variant of glioblastoma, which commonly demonstrates dural attachment. …”
Get full text
Article -
190
Trace elements‐based Auroshell gold@hematite nanostructure: Green synthesis and their hyperthermia therapy
Published 2023-02-01“…Cytotoxicity of Auroshell iron@gold nanoparticles against normal HUVEC cells and glioblastoma cancer cells was evaluated by 2,5‐diphenyl‐2H‐tetrazolium bromide method, water bath hyperthermia, and combined method of water bath hyperthermia and nano‐therapy. …”
Get full text
Article -
191
Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions
Published 2025-02-01“…Abstract Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. …”
Get full text
Article -
192
The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells
Published 2019-09-01“…Glioblastoma multiforme represents one of the deadliest brain tumor types, manifested by a high rate of recurrence and poor prognosis. …”
Get full text
Article -
193
Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway
Published 2024-12-01“…These findings highlight the therapeutic potential of CBD, suggesting that modulating NRF2 and autophagy pathways could represent a promising strategy for glioblastoma treatment.…”
Get full text
Article -
194
Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives
Published 2016-03-01“…Different human tumor cell lines, by including HCT-8 (colon carcinoma), MDA-MB-435 (melanoma) and SF-295 (glioblastoma) were continuous exposed to guanylhydrazone derivatives for 72 hours and growth inhibition of tumor cell lines and macrophages J774 was measured using tetrazolium salt (MTT) assay. …”
Get full text
Article -
195
Comprehensive single-cell pan-cancer atlas unveils IFI30+ macrophages as key modulators of intra-tumoral immune dynamics
Published 2025-01-01“…Pan-cancer analyses and glioblastoma multiforme (GBM) investigations collectively underscore IFI30's potential as a TME modulator, particularly in its interaction with M2-macrophages. …”
Get full text
Article -
196
Comparative analysis of lactaptin activity when produced in bacterial or eukaryotic expression systems
Published 2017-12-01“…Next, we measured the cytotoxic effects of the media conditioned by pEL1-transfected HEK293T cells, as assayed against the panel of three human cancer cell lines: MDA-MB-231 (adenocarcinoma), PC3 (prostate cancer), and T98G (glioblastoma). We show that EL1-derived lactaptin is at least 100-fold more cytotoxic than RL2. …”
Get full text
Article -
197
Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
Published 2025-02-01“…In-depth exploration of NUSAP1’s mechanisms in glioblastoma could enhance our understanding of its response to immunotherapy, suggesting that targeting NUSAP1 may offer therapeutic benefits for glioma patients.…”
Get full text
Article -
198
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
Published 2025-02-01“…Abstract Background Glioma, particularly glioblastoma (GBM), is a highly aggressive tumor with limited responsiveness to immunotherapy. …”
Get full text
Article -
199
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01“…TNG908 is being tested clinically in patients with MTAP-deleted tumors, including glioblastoma, in a Phase I/II clinical trial (NCT05275478).…”
Get full text
Article -
200
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
Published 2025-02-01“…Survival analysis illustrated that patients with high-SPHK1 expression, particularly glioblastoma and IDH-wildtype, tended to have a shorter survival time. …”
Get full text
Article